Literature DB >> 1802112

Cytokines and cell growth control.

M B Goldring1, S R Goldring.   

Abstract

Cellular proliferation in eukaryotic cells is associated with a highly organized sequence of events involving expression of growth-related genes. The growth regulatory cytokines such as platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), epidermal growth factor (EGF), and insulin-like growth factor (IGF-I) are thought to be responsible for initiating proliferation of fibroblasts and other connective tissue cells. The immunomodulatory cytokines, including interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma), are also known to modulate the growth response in nonimmune cells and regulate cellular metabolism by inducing expression of genes encoding biologically active molecules. While TGF-beta can induce anchorage-independent growth of nonneoplastic cells, it inhibits the proliferation of most normal cell types. Several of the cytokines that stimulate fibroblast proliferation may inhibit the growth of other cell types. Recent studies have also begun to assign specific roles to different cytokines in embryonic development and cellular differentiation. The growth response to some cytokines may be dependent upon the induction of other cytokines that then directly stimulate proliferation. Some cytokines may also modulate the responses induced by other cytokines by regulating receptor expression and other cellular events. Binding of cytokines to their specific membrane-associated receptors results in activation of signal transduction pathways, many of which involve phosphorylation of specific intercellular proteins. The final biological response is dependent ultimately on the induction and activation of trans-acting factors that regulate transcription by interacting with cis-acting DNA sequences in the target genes. Since many of these signaling and transcriptional events are common to distinct cytokines, many of which have different effects on proliferation in the same cell types, it is not clear how specificity is achieved in regulating the different biological responses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1802112

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  10 in total

Review 1.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.

Authors:  R P Atit; M J Crowe; D G Greenhalgh; R J Wenstrup; N Ratner
Journal:  J Invest Dermatol       Date:  1999-06       Impact factor: 8.551

3.  Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro.

Authors:  K Lange; A Gysler; M Bader; B Kleuser; H C Korting; M Schäfer-Korting
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

4.  Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts.

Authors:  C Sell; G Dumenil; C Deveaud; M Miura; D Coppola; T DeAngelis; R Rubin; A Efstratiadis; R Baserga
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

5.  The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulinlike growth factor 1 with its receptor.

Authors:  P Porcu; A Ferber; Z Pietrzkowski; C T Roberts; M Adamo; D LeRoith; R Baserga
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

6.  Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells.

Authors:  Z Pietrzkowski; C Sell; R Lammers; A Ullrich; R Baserga
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

7.  Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells.

Authors:  Geetanjalee Modha; Anne Blanchard; Janine Sidorchuk; Marcello Venditti; Robert Shiu; Yvonne Myal
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

8.  Effect of TNF, IL-1, and IL-6 on the proliferation of human Tenon's capsule fibroblasts in tissue culture.

Authors:  I A Cunliffe; P S Richardson; R C Rees; I G Rennie
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

9.  A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor.

Authors:  D Coppola; A Ferber; M Miura; C Sell; C D'Ambrosio; R Rubin; R Baserga
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

Review 10.  IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer.

Authors:  Olena Kourko; Kyle Seaver; Natalya Odoardi; Sameh Basta; Katrina Gee
Journal:  Front Oncol       Date:  2019-10-01       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.